Sponsor Pipeline

Wanbangde Pharmaceutical Group Co., LTD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Phase 3
2
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT07281872
Bioequivalence Study of WP205 in Healthy Participants		 Trial completed
2026-08-15 NCT07281872
Bioequivalence Study of WP205 in Healthy Participants		 date change Completion moved earlier: 2028-11-25 -> 2025-11-21
Active Trials by Phase
Phase 4
1
Phase 2/3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06704334 The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median… Cognitive Impairment After Brain Injury Recruiting
Phase 2/3
NCT07066826 Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release… Alzheimer Dementia Not Yet Recruiting
Phase 1
NCT07158099 Bioequivalence Study of WP205 in Healthy Subjects Therapeutic Equivalency, Healthy Not Yet Recruiting
Disease Areas
Alzheimer's Disease (1) Dementia (1)
Get alerts when Wanbangde Pharmaceutical Group Co., LTD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free